Stockreport

aTyr Pharma to Participate in September Investor Conferences

aTyr Pharma, Inc.  (ATYR) 
PDF SAN DIEGO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first [Read more]